Search
Patexia Community

Innovation, Technology, and IP News

The Interplay between Regulatory Exclusivities and Patent Litigation under the Hatch-Waxman Act

The Hatch-Waxman Act, officially known as the Drug Price Competition and Patent Term Restoration Act, revolutionized the pharmaceutical industry by balancing the interests of...

Objective Evidence in Determining Obviousness

MEDTRONIC, INC. v. TELEFLEX INNOVATIONS Before Moore, Lourie, and Dyk.  Appeal from the Patent Trial and Appeal Board. Summary: A close prima facie case of obviousness can be...

FDA Updates Cybersecurity Guidance

Written by:Matthew Ruth & Philip M. Nelson Going forward, medical device approval will require the device maker to provide cybersecurity information to the...

Patexia Insight 179: Best Patent Litigators of 2023: A Fusion of Analytics and Peer Reviews

In January, we delved into the intricacies of patent litigation in our third annual Patent Litigation Intelligence Report. This comprehensive study spanned five years, from July 1...

Fresh From the Bench: Latest Precedential Patent Case

CASE OF THE WEEK Medtronic, Inc. et al. v. Teleflex Innovations S.A.R.L., Appeal Nos. 2021-2356, -2358, -2361, -2363, and -2365 (Fed. Cir. May 24, 2023) In this week’s Case of...

ANDA Litigation: Navigating the Complexities of Patents and Generic Drug Approvals

In the world of pharmaceuticals, the Abbreviated New Drug Application (ANDA) process plays a critical role in the approval and market entry of generic drugs. However, the intersection...

FDA Approves Qalsody™ for Treatment of ALS

Written by: Douglas W. Crandell, Ph.D. & Robert J. Hilton, Ph.D. On April 25th, 2023, the U.S. Food and Drug Administration (FDA) approved QalsodyTM (tofersen) for the...

Feed tagged as "Alzheimer's Disease":
Princeton researchers have developed a way to make a common biological test more than 3 million times more sensitive. The greatly increased performance of the test... Read More »
Previous studies on animal models suggest several medical uses of resveratrol -- a compound present in red grapes, red grape juice, red wine, chocolate, tomatoes and... Read More »
Mount Sinai School of Medicine researchers have developed a biosynthetic polyphenol that improves cognitive function in mice with Alzheimer's disease (AD)... Read More »
Dementia is common in Parkinson’s disease (PD), because the brain pathology of Parkinson’s can affect memory. But it is very hard to determine which PD... Read More »
In the world's largest brain study, a team of more than 200 scientists from 100 institutions around the world collaborated to map the human genes that impact the... Read More »
Resistant malaria spreads as research funding challenges continue Resistant malaria strains have recently been reported in Cambodia, Thailand and parts of... Read More »
A new technique for analyzing brain images offers the possibility of using magnetic resonance imaging (MRI) to predict the progression and physical path of many... Read More »
Currently the only way to positively diagnose Alzheimer’s Disease is through brain biopsy or postmortem autopsy, both unpleasant procedures. But last week, Eli... Read More »
The US Food and Drug Administration has approved a radioactive diagnostic agent that can be used to evaluate a patient for Alzheimer’s disease and other... Read More »
Scientists have discovered a new gene mutation that could contribute to Alzheimer’s disease. It was known that specific genetic mutations were linked to... Read More »
Investigators from the University of Amsterdam, Netherlands, have shown that in most elderly patients invasive and expensive techniques, i.e. lumbar puncture and PET... Read More »
Insulin resistance in the brain precedes and contributes to cognitive decline above and beyond other causes of Alzheimer's disease, according to a new study from... Read More »
A research team led by the University of Melbourne has developed a new technique to track diseased proteins as they form clusters in brain diseases such as... Read More »
One of the trickiest parts of treating brain conditions is crossing the blood brain barrier (BBB), a blockade of cells that prevent both harmful toxins and helpful... Read More »
Research has found that the dementia drug donepezil, already widely used to treat mild to moderate Alzheimer's Disease (AD), also helps in moderate to severe... Read More »
Antibodies that block the process of synapse disintegration in Alzheimer's disease have been identified, raising hopes for a treatment to combat early cognitive... Read More »
A team of researchers with the Lawrence Berkeley National Laboratory (Berkeley Lab), using the exceptionally bright and powerful x-ray beams of the Advanced Light... Read More »
Patients’ own cardiac stem cells regrow heart muscle Many heart attacks leave behind scar tissue, which inhibits cardiac functions for a patient’s... Read More »
Alzheimer’s disease has had a strong presence in the news lately, between the Obama administration announcing a funding boost, the National Institute on Aging... Read More »
Neuroscientists at Case Western Reserve University School of Medicine have shown that use of the drug bexarotene in mice appears to quickly reverse the pathological... Read More »
Show more Newsfeed posts
Menu